Published by Coherent Market Insights
Posted on October 1, 2021
5 min readLast updated: February 1, 2026
The Hemostasis Diagnostics Market report provides insights into key players, regional growth, and market trends from 2021 to 2027.
Hemostasis Diagnostics Market (Forecast Period 2021-2028): The report provides a valuable source of insightful data for business strategists and competitive analysis of Hemostasis Diagnostics Market. The study covers important knowledge that makes the analysis document a handy resource for managers, analysts, business consultants and different key individuals get ready-to-access and self-analyzed study in conjunction with graphs and tables to assist perceive market trends, drivers and market challenges.It also highlights the restraints and opportunities expected to influence the market’s growth during the said period. The study provides a holistic perspective on the market’s growth throughout the above mentioned forecast period in terms of revenue(in US$ Mn) and Volume (Thousand Units), across different geographies.
To Access the Sample Report Click Here: https://www.coherentmarketinsights.com/insight/request-sample/434
Major Players In This Market Are: HORIBA, Ltd., Abbott Laboratories, Siemens AG, and Bio-Rad Laboratories, Inc.
Global Hemostasis Diagnostics Market – Insights
Hemostasis is a process used for healing wounds after a vascular injury and involves slowing and stopping the blood flow. Blood is gets converted to gelatinous state during the process. Three mechanisms — vasoconstriction, platelet plug formation, and blood coagulation maintain hemostasis in the body. Hemostasis diagnostics is used to identify the hemostatic defects that may lead to excessive bleeding. It also aids in determining the cause of excessive bleeding during the surgery and the hemostatic defects in patients with a history of excessive bleeding.
Global Hemostasis Diagnostics Market: Drivers
Increasing incidence of hemophilia is expected to boost growth of the global hemostasis diagnostics market over the forecast period. For instance, according to the National Hemophilia Foundation in 2012, the global incidence of hemophilia was estimated to be 400,000 people. Moreover, increasing cases of trauma, high number of surgeries, and rapid adoption of recombinant products is also expected to propel growth of the market.
Increasing technological development in molecular diagnostics, availability of cheap and biodegradable diagnostic products, chromogenic substrates, monoclonal antibodies, immunoassays, and increasing automation of laboratories is also expected to aid in growth of the market.
Global Hemostasis Diagnostics Market- Taxonomy
The global hemostasis diagnostics market is segmented on the basis of product type, technology, end user, and geography.
By Product Type
By Test Type
By End User
By Region
Global Hemostasis Diagnostics Market: Regional Analysis
North America is expected to hold dominant position in the global hemostasis diagnostics market over the forecast period. This is attributed to factors such as increasing installation of hemostasis diagnostics instruments and significant incidence of hemophilia in the U.S. For instance, according to the Centers for Disease Control and Prevention, in 2015, 20,000 people in the U.S. suffered from hemophilia.
Increasing prevalence of hemophilia is expected to aid in growth of the market in Europe. For instance, according to The European National Registry of Congenital Coagulopathies, 2017, the number of people suffering from hemostasis increased from 7000 in 2000 to over 11,000 in 2015.
The markets in emerging regions such as Asia Pacific and Latin America are driven by increasing healthcare expenditure and disposable income of the populace.
Global Hemostasis Diagnostics Market: Key Developments
In 2014, Sysmex Corporation, launched LIASAUTO P-FDP hemostasis reagent for automated coagulation analyzers to determine the status of blood hyperfibrinolysis and hypercoagulable
Buy This Premium Report Of Hemostasis Diagnostics Market Report 2021 With Flat USD 2000 OFF @ https://www.coherentmarketinsights.com/promo/buynow/434
In this study, the years considered to estimate the market size of Hemostasis Diagnostics are as follows:
History Year: 2017-2020
Base Year: 2020
Estimated Year: 2021
Forecast Year 2021 to 2028
The next part also sheds light on the gap between supply and consumption. Apart from the mentioned information, growth rate of Hemostasis Diagnostics Market in 2028 is also explained. Additionally, type wise and application wise consumption tables and figures of Hemostasis Diagnostics Market are also given.
Contact:
Coherent Market Insights
1001 4th Ave, #3200 Seattle, WA 98154, U.S.
Email: sales@coherentmarketinsights.com
United States of America: +1-206-701-6702
United Kingdom: +44-020-8133-4027
Japan: +050-5539-1737
India: +91-848-285-0837
The post Hemostasis Diagnostics Market Report 2021 with Leading Key Players and Regional Analysis 2027 appeared first on Gatorledger.
The article focuses on the Hemostasis Diagnostics Market, its key players, and regional growth analysis from 2021 to 2027.
Major players include HORIBA, Ltd., Abbott Laboratories, Siemens AG, and Bio-Rad Laboratories, Inc.
Increasing hemophilia cases, technological advancements, and rising healthcare expenditure drive the market growth.
Explore more articles in the Research Reports category
